Injured Spleen Flashcards
Most Common Solid Organ Injury after Blunt Trauma
Spleen
Asplenism Increase Risk For
nonencapsulated organisms
myocardial infarctions
deep vein thrombosis
strokes
pulmonary hypertension
malignancy.
Safe Candidates for Non Operative Management
-hemodynamic stability
-CT documentation and classification of the injury
-absence on CT scan of intraabdominal or retroperitoneal injuries mandating operative intervention
-transfusion of fewer than 2 units of PRBCs in a 24-hours
Other Exclusion Criteria for NOM
-Portal hypertension (Relative Contraindication)
-coagulopathy cannot be reversed
-Those who must urgently receive anticoagulation therapy
NOM
-Monitor Vitals
-Serial Abd Exam
-Serial Hb (6 Hrly for 48 Hrs)
-Angiography
-Early Enteral Feeding (Within 24-48 hrs)
-Repeat Ct (in 48 - 72 hrs)
-Bed Rest (for 24 hrs grade II-V)
-DVT Prophylaxis (Within 48 hrs ?)
Types of Angioembolization
-By metal Coils or Gel Foams
-Proximal Embolization or Distal
-Vaccination After Embolization
-Proximal embolization in settings where a localized lesion is not identified
It is faster to perform , associated with fewer complications.
A disadvantage is the inability to reintervene
-Distal embolization when a lesion is localized (more targeted therapy)
It carries a higher risk of complications including splenic infarct and abscess
has a higher hemorrhage control success
Splenic Repair Adjunct
Argon beam coagulation ( Radiofrequency Energy )
Fibrin glue Aka Tisseal ( Fibrinogen,thrombin,and CaCL)
Polyglycolic mesh wrap ( With Methylcellulose )
When to consider Splenectomy over Repair
Unstable Patient
damage Control
Other Injuries ( Needs Further Workups or interventions )
When to consider Partial Splenectomy
when early ligation of a branch of the splenic artery to a segment of the spleen results in major progress toward hemostasis
Provided that 50% of the splenic parenchyma attached to an identifiable vessel is viable
Vaccinations
2 Weeks Post Op :
pneumococcal vaccine Prevnar 13
Haemophilus influenza type B
meningococcal vaccines
The pneumococcal vaccine followed by Pneumovax 23 at least 8 weeks after the initial vaccination.
Subsequent boosters for pneumococcal and meningococcal administered in 5 years.
Seasonal flu vaccines should be provided